0.3473

5.05% 0.0167

Nexalin Technology Inc (NXL)

Overview News Price History Financials Discussions Forecast

Nexalin Technology Inc stock is traded at $0.3473, with a volume of 4,715. It is up +5.05% in the last 24 hours and down -27.80% over the past month. Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Previous Close:

$0.3306

Open:

$0.3325

24h Volume:

4,715

Relative Volume:

0.01

Market Cap:

$7.33M

Revenue:

$275.60K

Net Income/Loss:

$-8.33M

P/E Ratio:

-0.7519

EPS:

-0.4619

Net Cash Flow:

$-5.40M

1W Performance:

-0.77%

1M Performance:

-27.80%

6M Performance:

-30.28%

1Y Performance:

-52.42%

1-Day Range:

$0.3325

1-Week Range:

$0.325

$0.3599

52-Week Range:

$0.305

$2.00

Nexalin Technology Inc Stock (NXL) Company Profile

Name

Nexalin Technology Inc

Sector

Healthcare (1083)

Industry

Medical Devices (140)

Phone

(832) 260-0222

Address

1776 YORKTOWN, HOUSTON

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

NXL's Discussions on Twitter

Compare NXL vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXL Nexalin Technology Inc	0.3325	7.27M	275.60K	-8.33M	-5.40M	-0.4619
ABT Abbott Laboratories	114.75	198.01B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	330.92	130.41B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	92.36	120.48B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	49.62	75.37B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.54	53.19B	6.30B	1.07B	1.09B	1.8406

Nexalin Technology Inc Stock (NXL) Latest News

Aug 20, 2026

Nexalin Announces Capital Raise and Flexible Equity Facility - TipRanks

Aug 20, 2026

Nexalin Technology Raises $750,000 in Registered Direct Offering - Minichart

Aug 20, 2026

Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital - TradingView

Aug 20, 2026

Aug 19, 2026

Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingEPS Guidance Update - dars.gov.et

Aug 19, 2026

Aug 18, 2026

Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - The Globe and Mail

Aug 18, 2026

Aug 17, 2026

Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Aug 17, 2026

Aug 16, 2026

Nexalin Technology earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa

Aug 16, 2026

Nexalin Technology earnings missed, revenue fell short of estimates - Investing.com

Aug 16, 2026

Aug 14, 2026

Nexalin Technology Inc. (NASDAQ: NXL) Share Price, NXL Stock News, NXL Share Price & Updates - Kalkine

Aug 14, 2026

Aug 12, 2026

Nexalin Technology, Inc. 2Q 2026: Revenue $12.16K, EPS ($0.11) — 10-Q Summary - TradingView

Aug 12, 2026

Nexalin Technology (NXL) flags going concern risk as losses mount and Nasdaq warns - Stock Titan

Aug 12, 2026

Nexalin Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 12, 2026

Nexalin Technology | 8-K: Current report - Moomoo

Aug 12, 2026

Aug 10, 2026